Brief: Orion, MSD Initiate Two Phase 3 Trials Evaluating ODM-208/MK5684 in Certain Patients with Metastatic Castration-Resistant Prostate Cancer
05/01/2024 12:06
Jan 5 (Reuters) - Orion Oyj ORNBV.HE :
* ORION AND MSD ANNOUNCE INITIATION OF TWO PHASE 3 TRIALS
EVALUATING ODM-208/MK5684 IN CERTAIN PATIENTS WITH METASTATIC
CASTRATION-RESISTANT PROSTATE CANCER
Source text for Eikon: ID:nGNX3fLC8z
Further company coverage: ORNBV.HE
((Reuters.Briefs@thomsonreuters.com;))